News Releases Details

Otsuka receives approval for Rapirun^® H. Pylori Antibody Stick as in vitro diagnostic device on June 8, 2010

Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announce that it received approval for manufacture and marketing of Rapirun^® H. Pylori Antibody Stick as an in vitro diagnostic device for the rapid detection of the H. pylori antibody in urine on June 8, 2010.